In this video, Professor Christoph Correll defines the power, the sample size and effect size in clinical trials.
Published
20.05.2020
Permissions
Published
20.05.2020
Permissions
Related content
Highlights from the Global Burden of Disease 2021 Study
Stroke, migraine, Alzheimer’s Disease and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021
25.07.2024
Alzheimer’s Disease
The progression of addictive disorders over time
An illustration of the progression of addictive disorders over time.
24.07.2024
Substance Use Disorders
Global perspectives on Alzheimer’s disease diagnosis and treatment: challenges and considerations in resource-limited settings
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease and the leading cause of dementia worldwide, regardless of socioeconomic status.
09.07.2024
Alzheimer’s Disease